Liver cancer imaging: Role of CT, MRI, US and PET

Cancer Imaging

Volumn 4, Issue , 2004, Pages S42-S46

  Oliva, Maria Raquel ^a   Saini, Sanjay ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Computed tomography; Liver cancer imaging; Magnetic resonance imaging; Positron emission tomography; Ultrasonography

Indexed keywords

EID: 64549120121     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2004.0011     Document Type: Article

References (46)

1. Khan AN, Macdonald S, Amin Z. Liver, metastasis. http://www.emedicine.com/radio/topic394.htm. November 21, 2003.
2. Ackerman NB, Lien WM, Kondi ES et al. The blood supply of experimental liver metastases. Distribution of hepatic artery and portal vein blood to 'small' liver metastases. Distribution of hepatic artery and portal vein blood to 'small' and 'large' tumors. Surgery 1969;66:1067-72.
3. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-50.
4. Semelka RC, Worawattanakul S, Kelekis NL et al. Liver lesion detection, characterization, and effect on patient management: comparison of single-phase spiral CT and current MR techniques. J Magn Reson Imaging 1997;7:1040-7.
5. Karhunen PJ. Benign hepatic tumours and tumour like conditions in men. J Clin Pathol 1986;39:183-8.
6. Noone TC, Semelka RC, Balci NC, Graham ML. Common occurrence of benign liver lesions in patients with newly diagnosed breast cancer investigated by MRI for suspected liver metastases. J Magn Reson Imaging 1999;10:165-9.
7. Chezmar JL, Rumancik WM, Megibow AJ, Hulnick DH, Nelson RC, Bernardino ME. Liver and abdominal screening in patients with cancer: CT versus MR imaging. Radiology 1988;168:43-7.
8. Hopper KD, Singapuri K, Finkel A. Body CT and oncologic imaging. Radiology 2000;215:27-40.
9. Kulinna C, Helmberger T, Kessler M, Reiser M. Improvement in diagnosis of liver metastases with the multi-detector CT. Radiologe 2001;41:16-23.
10. Baron RL. Understanding and optimizing use of contrast material for CT of the liver. Am J Roentgenol 1994;163:323-31.
11. Zhao X, Wu N, Ouyang H. Imaging manifestations of tumors metastasized in fatty liver. Zhonghua Zhong Liu Za Zhi 1998;20:132-4.
12. Goldberg MA, Lee MJ, Fischman AJ, Mueller PR, Alpert NM, Thrall JH. Fluorodeoxyglucose PET of abdominal and pelvic neoplasms: potential role in oncologic imaging. Radiographics 1993;13:1047-62.
13. Tutt AN, Plunkett TA, Barrington SF, Leslie MD. The role of positron emission tomography in the management of colorectal cancer. Colorectal Dis 2004;6:2-9.
14. Pannu HK, Bristow RE, Cohade C, Fishman EK, Wahl RL. PET-CT in recurrent ovarian cancer: initial observations. Radiographics 2004;24:209-23.
15. Kinkel K, Lu Y, Both M, Warren RS, Thoeni RF. Detection of hepatic metastases from cancers of the gastrointestinal tract by using non-invasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 2002;224:748-56.
16. Kalva S, Sahani D, Ryan D, Fishman A, Hahn P, Saini S. Detection of liver metastases from GI cancer: comparison of high-resolution Mn-DPDP contrast-enhanced MRI and FDG-PET. In: RSNA '03 Gastrointestinal Session, Scientific Papers, Radiological Society of North America.
17. Solbiati L, Cova L, Ierace T, Marelli P, Dellanoce M. Liver cancer imaging: the need for accurate detection of intrahepatic disease spread. J Comput Assist Tomogr 1999;23(Suppl. 1):S29-37.
18. Weinmann HJ, Ebert W, Misselwitz B, Schmitt-Willich H. Tissue-specific MR contrast agents. Eur J Radiol 2003;46:33-44.
19. Sahani D, Bluemke D, Shamsi K, Breuer J, Belzer T, Saini S. MR imaging using a liver specific contrast agent (gadolinium-EOB-DTPA): US multicenter phase III study of efficacy and safety. In: RSNA '03 Gastrointestinal Session, Scientific Papers, Radiological Society of North America.
20. Bluemke DA, Weber TM, Rubin D et al. Hepatic MR imaging with ferumoxides: multicenter study of safety and effectiveness of direct injection protocol. Radiology 2003;228:457-64.
21. Bluemke DA, Paulson EK, Choti MA, De Sena S, Clavien PA. Detection of hepatic lesions in candidates for surgery: comparison of ferumoxides-enhanced MR imaging and dualphase helical CT. Am J Roentgenol 2000;175:1653-8.
22. Kondo H, Kanematsu M, Hoshi H et al. Preoperative detection of malignant hepatic tumors: comparison of combined methods of MR imaging with combined methods of CT. Am J Roentgenol 2000;174:947-54.
23. Reimer P, Tombach B. Hepatic MRI with SPIO: detection and characterization of focal liver lesions. Eur Radiol 1998;8:1198-204.
24. Ros PR, Freeny PC, Harms SE et al. Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. Radiology 1995;196:481-8.
25. Schwartz LH, Seltzer SE, Tempany CM et al. Superparamagnetic iron oxide hepatic MR imaging: efficacy and safety using conventional and fast spin-echo pulse sequences. J Magn Reson Imaging 1995;5:566-70.
26. Ward J, Guthrie JA, Wilson D et al. Colorectal hepatic metastases: detection with SPIO-enhanced breath-hold MR imaging-comparison of optimized sequences. Radiology 2003;228:709-18.
27. Semelka RC, Helmberger TK. Contrast agents for MR imaging of the liver. Radiology 2001;218:27-38.
28. Van Hoe L, Baert AL, Gryspeerdt S et al. Dual-phase helical CT of the liver: value of an early-phase acquisition in the differential diagnosis of noncystic focal lesions. Am J Roentgenol 1997;168:1185-92.
29. Yun EJ, Choi BI, Han JK et al. Hepatic hemangioma: contrastenhancement pattern during the arterial and portal venous phases of spiral CT. Abdom Imaging 1999;24:262-6.
30. Horton KM, Bluemke DA, Hruban RH, Soyer P, Fishman EK. CT and MR imaging of benign hepatic and biliary tumors. Radiographics 1999;19:431-51.
31. Oudkerk M, Torres CG, Song B et al. Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CT. Radiology 2002;223:517-24.
32. Pastor CM, Planchamp C, Pochon S et al. Kinetics of gadobenate dimeglumine in isolated perfused rat liver: MR imaging evaluation. Radiology 2003;229:119-25.
33. Saini S, Nelson RC. Technique for MR imaging of the liver. Radiology 1995;197:575-7.
34. Kubaska S, Sahani DV, Saini S, Hahn PF, Halpern E. Dual contrast-enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization. Clin Radiol 2001;56:410-5.
35. Harisinghani MG, Hahn PF. Computed tomography and magnetic resonance imaging evaluation of liver cancer. Gastroenterol Clin North Am 2002;31:759-76.
36. Youk CM, Choi MS, Paik SW et al. Early diagnosis and improved survival with screening for hepatocellular carcinoma. Taehan Kan Hakhoe Chi 2003;9:116-23.
37. Nicolau C, Bianchi L, Vilana R. Gray-scale ultrasound in hepatic cirrhosis and chronic hepatitis: diagnosis, screening, and intervention. Semin Ultrasound CT MR 2002;23:3-18.
38. Vogl TJ, Eichler K, Zangos S, Mack M, Hammerstingl R. Hepatocellular carcinoma: role of imaging diagnostics in detection, intervention and follow-up. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2002;174:1358-68.
39. Libbrecht L, Bielen D, Verslype C et al. Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations. Liver Transpl 2002;8:749-61.
40. Baron RL, Peterson MS. From the RSNA refresher courses: screening the cirrhotic liver for hepatocellular carcinoma with CT and MR imaging: opportunities and pitfalls. Radiographics 2001;21 Spec No: S117-32.
41. Yamashita Y, Mitsuzaki K, Yi T et al. Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver. Radiology 1996;200:79-84.
42. Laghi A, Iannaccone R, Rossi P et al. Hepatocellular carcinoma: detection with triple-phase multi-detector row helical CT in patients with chronic hepatitis. Radiology 2003;226:543-9.
43. Murakami T, Kim T, Takamura M et al. Hypervascular hepatocellular carcinoma: detection with double arterial phase multi-detector row helical CT. Radiology 2001;218:763-7.
44. Krinsky GA, Lee VS, Theise ND et al. Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation. Radiology 2001;219:445-54.
45. Van Thiel DH, Wright HI, Fagiuoli S, Caraceni P, Rodriguez-Rilo H. Preoperative evaluation of a patient for hepatic surgery. J Surg Oncol Suppl 1993;3:49-51.
46. Ozeki Y, Uchiyama T, Katayama M, Sugiyama A, Kokubo M, Matsubara N. Extended left hepatic trisegmentectomy with resection of main right hepatic vein and preservation of middle and inferior right hepatic veins. Surgery 1995;117:715-7.